1-2 of 2
François Demeocq, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-Dose Methotrexate Seems to Benefit Only to Standard-Risk BCP-ALL Patients with Good Early Response to Chemotherapy: Final Analysis of the FRALLE93B Study

Thierry Leblanc, MD, Judith Landman-Parker, MD, Marie-Françoise Auclerc, MD, Krystell Desseaux, Christiane Vermylen, MD, Claudine Schmitt, MD, Virginie Gandemer, MD, Odile Lejars, MD, Jean-Pierre Vannier, MD, François Demeocq, MD, Christian Berthou, MD, Gérard Couillault, MD, Brigitte Pautard, MD, Claire Berger, MD, Lionel De Lumley, MD, Marianne Debré, MD, Gérard Michel, MD, Yves Perel, MD, Guy Leverger, MD, Andre Baruchel, MD
Journal: Blood
Blood (2008) 112 (11): 10.
https://doi.org/10.1182/blood.V112.11.10.10
Published: 2008
Journal Articles

Two Decades of Progresses in Adolescents with Acute Lymphoblastic Leukemia (ALL) Treated in the FRALLE Protocols: Adolescence Is No More a Bad Prognostic Feature If an Intensive Chemotherapy Is Applied.

Andre Baruchel, MD, Marie-Françoise Auclerc, MD, Yves Perel, MD, Françoise Mechinaud, MD, Anne Auvrignon, MD, Claudine Schmitt, MD, Christophe Piguet, MD, Odile Lejars, MD, Christian Berthou, MD, François Demeocq, MD, Pascale Schneider, MD, Virginie Gandemer, MD, Gérard Michel, MD, Jean-Michel Cayuela, Pharm D, Thierry Leblanc, MD, Guy Leverger, MD, the FRALLE Group
Journal: Blood
Blood (2006) 108 (11): 1852.
https://doi.org/10.1182/blood.V108.11.1852.1852
Published: 2006